Go Deep
Beam Therapeutics Inc.
Beam Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,406 | -35.9 | 2.36 | 0.23 | 2,326.56 |
| Oct 2026 | 19,547 | -34.8 | 2.29 | 0.23 | 2,245.51 |
| Oct 2026 | 19,352 | -36.4 | 2.39 | 0.23 | 2,348.39 |
| Oct 2026 | 19,579 | -34.5 | 2.27 | 0.23 | 2,222.96 |
| Oct 2026 | 19,449 | -35.6 | 2.34 | 0.23 | 2,293.61 |
| Oct 2026 | 19,316 | -36.7 | 2.41 | 0.23 | 2,363.77 |
| Oct 2026 | 19,332 | -36.5 | 2.40 | 0.23 | 2,349.42 |
| Oct 2026 | 19,382 | -36.1 | 2.38 | 0.23 | 2,318.24 |
Beam Therapeutics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 490,000.0 | 31,738,000.0 | 114,109,000.0 | 9,698,000.0 |
| Net Profit | -122,678,000.0 | -94,318,000.0 | 244,297,000.0 | -112,728,000.0 |
| EPS | -1.2 | -0.9 | 2.4 | -1.1 |
Beam Therapeutics Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 139,743,000.0 | 63,518,000.0 | 377,709,000.0 | 60,920,000.0 | — |
| Net Profit | -79,992,000.0 | -376,742,000.0 | -132,527,000.0 | -289,088,000.0 | — |
| EPS | -0.8 | -4.6 | -1.7 | -4.1 | — |
Beam Therapeutics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,481,177,000.0 | 1,103,824,000.0 | 1,459,714,000.0 | 1,341,714,000.0 | — |
| Total Liabilities | 242,819,000.0 | 370,279,000.0 | 478,385,000.0 | 608,240,000.0 | — |
| Total Equity | 1,238,358,000.0 | 733,545,000.0 | 981,329,000.0 | 733,474,000.0 | — |
Owes vs Owns
Beam Therapeutics Inc. owed $0.23 for every $1 it owned in Jun 2026, down from $0.45 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.16× | 0.34× | 0.33× | 0.45× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Beam Therapeutics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 84.1%Fixed assets (tangible) 13.9%Other assets 2.1%
How it's funded — Dec 2025
Short-term debt 1.0%Long-term debt 9.4%Payables 0.7%Other liabilities 5.3%Shareholders' equity 83.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,245.2 | 850.7 | 1,189.9 | 1,078.1 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 205.2 | 216.3 | 237.8 | 234.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 30.8 | 36.8 | 32.0 | 29.4 |
| Liabilities & equity | ||||
| Short-term debt | 14.4 | 13.5 | 12.8 | 10.4 |
| Long-term debt | 139.8 | 148.0 | 159.9 | 168.6 |
| Payables | 10.2 | 3.9 | 1.6 | 9.0 |
| Other liabilities | 78.5 | 205.0 | 304.1 | 420.2 |
| Shareholders' equity | 1,238.4 | 733.5 | 981.3 | 733.5 |
| Net tangible assets | 1,238.4 | 733.5 | 981.3 | 733.5 |
Beam Therapeutics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -345,102,000.0 | -347,246,000.0 | -149,195,000.0 | 22,527,000.0 | — |
| Investing Activities | -121,438,000.0 | 185,007,000.0 | 71,840,000.0 | -461,336,000.0 | — |
| Financing Activities | 478,049,000.0 | 7,736,000.0 | 276,448,000.0 | 111,590,000.0 | — |